Leaflet: information for the user
Tadalafilo Teva-ratiopharm 5 mg film-coated tablets
Read this leaflet carefully before you start taking this medicine, because it contains important information for you.
1. What Tadalafilo Teva-ratiopharm is and what it is used for
2. What you need to know before you start taking Tadalafilo Teva-ratiopharm
3. How to take Tadalafilo Teva-ratiopharm
4. Possible side effects
5. Storage of Tadalafilo Teva-ratiopharm
6. Contents of the pack and additional information
TadalafiloTeva-ratiopharm contains the active ingredient tadalafilo, which belongs to a group of medicines called phosphodiesterase type 5 inhibitors.
Tadalafilo Teva-ratiopharm is indicated in adult men for the treatment of:
- Erectile dysfunction. This is when a man cannot get or keep an erection firm enough for sexual activity. Tadalafilohas shown a significant improvement in the ability to obtain a lasting erection of the penis suitable for sexual activity.
After sexual stimulation, tadalafilo acts by helping to relax the blood vessels in your penis, allowing blood to flow into the penis. The result is an improvement in erectile function. Tadalafilo will not help if you do not have erectile dysfunction.
It is essential to note that tadalafilo is not effective without sexual stimulation.Therefore, you and your partner should stimulate yourselves in the same way as you would if you were not taking a medication for erectile dysfunction.
- Urinary symptoms associated with a common disease calledbenign prostatic hyperplasia.This is when the prostate gland enlarges with age. Symptoms include difficulty starting to urinate, feeling that the bladder is not fully emptied, needing to urinate more frequently, even at night. Tadalafilo improves blood flow and relaxes the muscles of the prostate and bladder, which may reduce the symptoms of benign prostatic hyperplasia. Tadalafilo has shown to improve these urinary symptoms in as short a time as 1-2 weeks after starting treatment.
Do not take Tadalafilo Teva-ratiopharm if:
Warnings and precautions
Consult your doctor or pharmacist before starting to take Tadalafilo Teva-ratiopharm.
Be aware that sexual activity can pose a possible risk to patients with heart problems, due to the additional strain it puts on the heart. If you have a heart problem, consult your doctor.
Since benign prostatic hyperplasia and prostate cancer can have the same symptoms, your doctor will perform a prostate cancer review before starting treatment with Tadalafilo Teva-ratiopharm for benign prostatic hyperplasia. Tadalafilo Teva-ratiopharm is not intended to treat prostate cancer.
Before taking Tadalafilo Teva-ratiopharm, inform your doctor if you have:
- Sickle cell anemia (an abnormality of red blood cells).
- Multiple myeloma (bone marrow cancer).
- Leukemia (blood cell cancer).
- Any penile deformity.
- A severe liver problem.
- A severe kidney problem.
Tadalafil is not known to be effective in patients who have undergone:
- Pelvic surgery.
- A surgical intervention in which the prostate has been completely or partially removed and the prostate nerves have been cut (radical prostatectomy without neurovascular bundle preservation).
If you experience a sudden decrease or loss of vision or your vision is distorted while taking tadalafil, stop taking tadalafil and immediately contact your doctor.
A decrease or sudden loss of hearing has been observed in some patients taking tadalafil. Although it is not known if the event is directly related to tadalafil, if you experience a decrease or sudden loss of hearing, stop taking Tadalafilo Teva-ratiopharm and immediately contact your doctor.
Tadalafil is not intended for use in women.
Children and adolescents
Tadalafilo Teva-ratiopharm should not be used in children or adolescents under 18 years old.
Taking Tadalafilo Teva-ratiopharm with other medications
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
Do not take Tadalafilo Teva-ratiopharm if you are already using nitrates (see “Do not take Tadalafilo Teva-ratiopharm”).
Some medications may be affected by tadalafil or may affect the proper functioning of tadalafil. Inform your doctor or pharmacist if you are using:
Taking Tadalafilo Teva-ratiopharm with beverages and alcohol
The information about the effect of alcohol is found in section 3. Orange juice may affect the proper functioning of tadalafil and should be taken with caution. Consult your doctor for more information.
Fertility
In dogs treated, a decrease in sperm production by the testicles was observed. A decrease in sperm count has been observed in some men. It is unlikely that these effects will cause infertility.
Driving and operating machines
Some men who took tadalafil during clinical trials experienced dizziness. Check carefully how you react when taking the tablets before driving or operating machines.
Tadalafilo Teva-ratiopharm contains lactose and sodium
This medication contains lactose. If your doctor has told you that you have a certain sugar intolerance, consult with him before taking this medication.
This medication contains less than 23 mg of sodium (1 mmol) per coated tablet; this is, essentially “sodium-free”.
Follow exactly the administration instructions of this medication as indicated by your doctor or pharmacist.If in doubt, consult your doctor or pharmacist again.
Tadalafilo Teva-ratiopharm tablets are for oral administration only in men. Swallow the tablet whole with a little water. Tablets can be taken with or without food.
Consuming alcohol may temporarily lower your blood pressure. If you have taken or are planning to take Tadalafilo Teva-ratiopharm, avoid excessive alcohol consumption (blood alcohol level of 0.08% or higher), as it may increase the risk of dizziness when standing up.
For the treatment of erectile dysfunction
The recommended doseis one 5 mg tablet once a day, approximately at the same time. Your doctor may adjust the dose to 2.5 mg based on your response to Tadalafilo Teva-ratiopharm. This will be done by taking one 2.5 mg tablet.
Do not take Tadalafilo Teva-ratiopharm more than once a day.
Tadalafilo Teva-ratiopharm taken daily may be useful in men who anticipate engaging in sexual activity two or more times a week.
Tadalafilo Teva-ratiopharm taken daily allows you to achieve an erection at any time during the 24 hours of the day, as long as there is sexual stimulation.
It is essential to inform you that tadalafilo is not effective without sexual stimulation. Therefore, you and your partner should stimulate yourselves in the same way as you would without taking a medication for erectile dysfunction.
Consuming alcohol may affect your ability to achieve an erection.
For the treatment of benign prostatic hyperplasia
The doseis one 5 mg tablet once a day, approximately at the same time.
If you have benign prostatic hyperplasia and erectile dysfunction, the dose remains one 5 mg tablet once a day.
Do not take Tadalafilo Teva-ratiopharm more than once a day.
If you take more TadalafiloTeva-ratiopharm than you should
Consult your doctor. You may experience adverse effects described in section 4.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately, or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested. It is recommended to bring the packaging and the medication leaflet to the healthcare professional.
If you forgot to take TadalafiloTeva-ratiopharm
Take your dose as soon as you remember, but do not take a double dose to compensate for the missed doses. Do not take Tadalafilo Teva-ratiopharm more than once a day.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
If you experience any of the following side effects, stop using the medicine and seek medical help immediately:
Other side effects that have been reported:
Frequent(may affect up to 1 in 10 people)
Rare(may affect up to 1 in 100 people)
Very rare(may affect up to 1 in 1,000 people)
It has also been reported that rare cases of heart attack and stroke have occurred in men taking tadalafil. Most of these men had some heart problem before taking this medicine.
Very rarely, cases of partial or permanent loss of vision in one or both eyes have been reported.
Some rare additional side effects have been reported in men taking tadalafil that were not reported during clinical trials. These include:
The most common side effect reported in men over 75 years old taking tadalafil has been dizziness. In men over 65 years old taking tadalafil, the most common side effect reported has been diarrhea.
Reporting side effects:
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keepthis medicationout of the sight and reach of children.
Do not usethis medicationafter the expiration date that appears onthe box and on the blister packafter CAD. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medicines should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection pointat the pharmacy. Ask your pharmacisthow to dispose ofpackaging and medicationsyou no longer need. This will help protect the environment.
Composition of TadalafilTeva-ratiopharm
Each film-coated tablet contains 5 mg of tadalafil.
The film coating of the tablet contains polyvinyl alcohol, macrogol, titanium dioxide (E171), talc, and iron oxide yellow (E172).
Appearance of the product and contents of the package
TadalafilTeva-ratiopharm 5 mg are film-coated, yellow to brown tablets, oval in shape, printed on one side with “5”, and flat on the other side, with a length of 8.1 mm and a width of 4.1 mm.
TadalafilTeva-ratiopharm 5 mg film-coated tablets are available in blisters of 14, 18, 28, 30, or 84 film-coated tablets, or in 28x1 or 98x1 film-coated tablets in a perforated single-dose blister.
Only some package sizes may be marketed.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder
Teva Pharma, S.L.U.
C/Anabel Segura, 11 Edificio Albatros B, 1st Floor
Alcobendas, 28108 Madrid (Spain)
Responsible manufacturer
TEVA Pharmaceutical Works Private Limited Company
Debrecen, Pallagi út 13, H-4042
Hungary
or
TEVA UK Ltd
Brampton Road, Hampden Park, Eastbourne, East Sussex,
BN22 9AG
United Kingdom
or
Teva Operations Poland Sp. z.o.o
ul. Mogilska 80, Krakow 31-546
Poland
or
TEVA PHARMA S.L.U.
C/C, n. 4, Poligono Industrial Malpica, 50016 Zaragoza
Spain
or
Merckle GmbH
Ludwig-Merckle-Straße 3, Blaubeuren 89143
Germany
or
Merckle GmbH
Graf-Arco-Str. 3, Ulm 89079
Germany
or
PLIVA Hrvatska d.o.o. (PLIVA Croatia Ltd.)
Prilaz baruna Filipovica 25, 10000 Zagreb
Croatia
or
Balkanpharma-Dupnitsa AD
3 Samokovsko Shosse Str.
Dupnitsa 2600
Bulgaria
This medicinal product is authorized in the member states of the European Economic Area with the following names:
Germany:Tadalafil AbZ 5 mg Filmtabletten
Spain:TadalafiloTeva-ratiopharm 5 mg film-coated tablets EFG
Portugal:Tadalafil ratiopharm 5 mg film-coated tablets
Last revision date of thisleaflet: November 2023
Detailed and updated information on this medicinal product is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
You can access detailed and updated information on this medicinal product by scanning the QR code included in the packaging with your smartphone. You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/80044/P_80044.html
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.